Saroja Pharma Industries

About the company

## **About the Saroja Pharma Industries  IPO** Incorporated in 2019, Saroja Pharma Industries supplies specialty chemicals and active pharmaceutical ingredients (API) used for pharmaceutical products, human and veterinary medicine. Company accepts product demand from its clients, manufactures it through suppliers and dispatches finished products across India and abroad. Company’s clientele base has increased in the past two years. Hence, the company plans to foray into manufacturing of API Pharma products. Saroja Pharma has a presence in various countries, including  Pakistan, UK, Jordan, Singapore, Belarus, Uruguay, Australia, Germany, Egypt and others through registered and/or under registration products. The company aims to provide a comprehensive range of pharmaceutical solutions that cater to the diverse needs of its expanding customer base. Now, Saroja Pharma Industries is coming out with its initial public offer (IPO). The IPO will be a fresh issue. The money raised through the fresh issue will be utilised to set-up a manufacturing unit, to repay its unsecured loans & for public issue expenses. ## **Here are key details about the Saroja Pharma Industries  IPO :** Company Name| Saroja Pharma Industries |  | Company Type| Private ---|---|---|---|--- IPO Type|SME|

Financial performance (₹ Cr)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   31 Aug 2023

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   05 Sept 2023

   Last day to place your bid

3. Basis of Allotment

   Completed
   02 Sept 2023

   Share allotment finalised

4. Refund Initiation

   Completed
   11 Sept 2023

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   08 Sept 2023

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   13 Sept 2023

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.